370 likes | 498 Views
University of Debrecen. 450 years; the oldest institution of higher education of continuous history in Hungary. Number of students: 29 121 Academic staff (full time): 1 413 Non-academic staff (full time): 5 312 Annual budget (2007): ~68,6 billion HUF ( 275 million € ).
E N D
University of Debrecen • 450 years; the oldest institution of higher education of continuous history in Hungary • Number of students:29 121 • Academic staff (full time): 1 413 • Non-academic staff (full time): 5 312 • Annual budget (2007): ~68,6 billion HUF (275 million €) 15 faculties in three centers Centre of Arts, Humanities and Sciences Medical and Health Science Center Centre for Agricultural Sciences and Engineering • Medicine • Dentistry • Pharmacy • Public Health • Health Sciences • Science andTechnology • Humanities • Informatics • Economics • Law • Music • Education • Agriculture • Engineering • Rural Development
Molecular Medicine Molecular Cell and Immune Biology Clinical Medicine Clinical Medicine Health Sciences Dentistry Pharmacology and Pharmaceutical Sciences Mathematics and computing Informatics Physics Chemistry Earth Sciences Biology and Environmental Sciences Graduate and PhD schools • History and Ethnology • Literature • Linguistics • Humanities (Philosophy, Psychology and Education) • Law • Economics • Management and Business Administration • Crop Production, Horticulture and Food Sciences • Crop Production, Horticulture and Regional Sciences • Animal Husbandry
Based on its research activity UD ranks among the top three universities in Hungary (Ministry of Education); 70% of the academic staff hold PhD degree; 26 members of the Hungarian Academy of Sciences (10 new ones since the year 2000); 11 research groups sponsored by special grant of the Hungarian Academy of Sciences; 23 Ph.D. schools (highest number in Hungary); Close to 800 PhD students; 150-200 new PhD degrees issued per annum; R&D income ~4,5 billion HUF/year (~18 million €). University of Debrecen: The researchuniversity
RCMM - introduction 1. Research Centre for Molecular Medicine Medical and Health Science Center University of Debrecen Centre of Excellence of the European Union (2002)
RCMM - introduction 2. • Research institute • Clinically oriented and basic cutting edge research • Collaborating research laboratories • Core facilities • International partner institutions
RCMM - Basic Research 1. • Molecular Mechanism of Apoptosis • Apoptosis Signaling • Nuclear Hormone Receptor • Retroviral Biochemistry • Dendritic Cell Research
RCMM - Basic Research 2. • Cell Biophysics • Lymphocyte Electrophysiology • Receptor Tyrosine Kinases • Cell Biology • Membrane Dynamics
RCMM - Basic research 3. • Signal Transfer • Oxidative Stress and ADP-ribosylation • Protein Phosphatases in Cellular Signaling • Protein Dephosphorylation
RCMM - Basic Research 4. • Cellular and Molecular Physiology • Calcium Homeostasis and Transmembrane Signaling • K+ Channels in Excitable and Non-excitable Structures
RCMM - Clinical Research • Haemostasis Thrombosis and Vascular Biology Research • Vascular Biology Research • Earpathology • Genetics of Corneal and Retinal Dystrophies and Degenerations • Cardiology, Clinical Physiology
RCMM - Core Facilities • Debrecen Clinical Genomics Centre • High-throughput Screening (HTS) Facility • Cell Analysis Core Facility • Lipidomics Core Facility • Laboratory Animal Core Facility • Biomolecular Interaction Laboratory • Proteomics Core Facility
Debrecen Award for Molecular Medicine • International annual price of 10 000 EUR • Aim: encouraging, recognizing and promoting extraordinary research results • Winner in 2008: Bruce M. Spiegelman
http://rcmm.dote.hu Please visit our web site.
MOLMEDREX project Coordination and Support Action FP7-REGPOT-2008-1/229920
RCMM • Research Centre for Molecular Medicine • Basic and cutting edge biomedical research • Research Groups + Core Facilities • Centre of Excellence
MOLMEDREX - aims • Human potential • Research equipment • Mobility of researchers • Dissemination of results
Selected Research Fields Genomics/Gene expression- Personalized medicine Advanced Imaging High throughput screening in an academic setting
MOLMEDREX - Work Packages • WP1 Development of the research potential in strategic areas by twinning and partnerships • WP2 Increasing human potential of RCMM • WP3 Upgrading infrastructure • WP4 Establishing RCMM as a regional knowledge centre • WP5 Dissemination • WP6 Project management
MOLMEDREX - WP1 • Twinning & Partnership • Twinning Partners: DKFZ, EMBL • Strategic Partners: 14 leading universities • Aim: expanding RTD capacity, gaining further expertise and new technologies in genomics, imaging and HTS • Collaborations: secondments, lab meetings, visits, lectures seminars
MOLMEDREX- WP2 • Increasing human potential of RCMM • Aim: reinforcing S & T competitiveness, upgrading RTD capability in new, highly competent research fields (personalized medicine, stem cell research, molecular imaging etc.) • 4 senior and 4 junior researcher positions are offered in different fields
MOLMEDREX - WP3 • Upgrading infrastructure • Aims: broadening the scope of methods, improving efficiency • Equipment purchased is unique in the region and nationwide (Microarray platform, Semi-automatized Patch Clamp robot, Andor camera, Microplate dispenser, centrifuge, UV irradiator, TIRF PALM Microscope purchase in progress)
MOLMEDREX - WP4 • Establishing RCMM as a regional knowledge centre in the field of biomedical research • Training courses, conferences, workshops will be organized • E.g. GeneSpring course, Practical Course on Techniques in Free Radical Biology (http://febs.unideb.hu) • Co-funding by EMBO or FEBS
MOLMEDREX - WP5 • Dissemination of results • Aims: dissemination, marketing, promotion of results • E-platform, newsletters, brochures, publications, presentation at international conferences, Alumni program, Annual report etc. • Target groups: regional, national, EU, global research facilities in academia and industry (Biotech, Pharma), policy-makers, politicians, legislative bodies, selected patient groups, multiple sectors of the lay public
MOLMEDREX - WP6 • Aims: administration, coordination and motivation of all the activities in the project • Advisory group (senior scientists of UD, local biotech, local government, national R&D agency)
Expected results of MOLMEDREX project As a result RCMM will become a more potent and prepared research centre in the Eastern part of Hungary with an improved human and infrastructural capacity to tackle key issues in molecular medicine for the benefit of the population of the region.
http://molmedrex.dote.hu Please visit our web site!
Services • Study design, consulting • Patient recruitment • Biobanking • Integrated database • Functional analysis: Functional genomic analysis services and epigenomic analysis services • Data analysis / mining
Infrastructure • Affymetrix GeneChip 3000 7G System, • 2 pc ABI 7900 Real-time quantitative PCR instruments, • ABI 310 Avant DNA sequencer, • 2 pc Light Cycler 480 (Roche) • MMI UV cut laser microdissector, • Tecan Genesis RSP150 • Tecan Miniprep 75 • MagnaPure LC • FaCScalibur • Agilent Bioanalyzer 2100 • 2 pc NanoDrop 1000
Methods • Microarray technology • Real-time quantitative PCR including Minimal residual disease (MRD) analysis, miRNA detection, Genotyping qPCR Assay (SNP detection), TaqMan Low Density Array (Microfluidics Card) • Sanger DNA sequencing; • Nucleic acid isolation; • Molecular cloning • Chromatin immunoprecipitation (ChIP) • Methylated DNA Immunoprecipitation (MeDIP)
References • Debrecen Clinical Genomics Center 2001 – 2007 • 2005-2007 Biosystems International SAS, • 2006-2007 Richter Gedeon Nyrt., • 2006-2007 AstraZeneca • 2001-2007 Pfizer Global Research • UD-GenoMed Ltd. 2008 –